Vaxcyte, Inc. (NASDAQ:PCVX) filed a Form 8-K with the Securities and Exchange Commission on February 24, 2026, disclosing a material event. Vaxcyte, Inc.'s stock currently trades…
Vaxcyte, Inc. (NASDAQ:PCVX) filed a Form 8-K with the Securities and Exchange Commission on February 24, 2026, disclosing a material event.
Vaxcyte, Inc.'s stock currently trades at $61.35 with a market capitalization of $5.8B. The Healthcare company's stock moved following the disclosure.
Current market data
NASDAQ · PCVX
$59.84
Down: -$1.32 · -2.16%
Live quote updated
Keep reading
price ·
institutional ·
earnings ·
sec_filing ·
